MREO
Price
$2.05
Change
+$0.05 (+2.50%)
Updated
Oct 17 closing price
Capitalization
326.15M
31 days until earnings call
TRDA
Price
$5.87
Change
-$0.31 (-5.02%)
Updated
Oct 17 closing price
Capitalization
223.28M
24 days until earnings call
Interact to see
Advertisement

MREO vs TRDA

Header iconMREO vs TRDA Comparison
Open Charts MREO vs TRDABanner chart's image
Mereo BioPharma Group
Price$2.05
Change+$0.05 (+2.50%)
Volume$1.47M
Capitalization326.15M
Entrada Therapeutics
Price$5.87
Change-$0.31 (-5.02%)
Volume$126.03K
Capitalization223.28M
MREO vs TRDA Comparison Chart in %
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MREO vs. TRDA commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MREO is a Hold and TRDA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (MREO: $2.00 vs. TRDA: $6.18)
Brand notoriety: MREO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MREO: 66% vs. TRDA: 57%
Market capitalization -- MREO: $326.15M vs. TRDA: $223.28M
MREO [@Biotechnology] is valued at $326.15M. TRDA’s [@Biotechnology] market capitalization is $223.28M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MREO’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • MREO’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, MREO is a better buy in the long-term than TRDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MREO’s TA Score shows that 4 TA indicator(s) are bullish while TRDA’s TA Score has 6 bullish TA indicator(s).

  • MREO’s TA Score: 4 bullish, 5 bearish.
  • TRDA’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than MREO.

Price Growth

MREO (@Biotechnology) experienced а -4.76% price change this week, while TRDA (@Biotechnology) price change was -8.98% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +16.02%, and the average quarterly price growth was +79.42%.

Reported Earning Dates

MREO is expected to report earnings on Nov 18, 2025.

TRDA is expected to report earnings on Nov 11, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MREO($326M) has a higher market cap than TRDA($223M). MREO YTD gains are higher at: -41.429 vs. TRDA (-66.050). MREO has higher annual earnings (EBITDA): -47.49M vs. TRDA (-92.26M). TRDA has more cash in the bank: 354M vs. MREO (56.1M). MREO has less debt than TRDA: MREO (601K) vs TRDA (54.7M). TRDA has higher revenues than MREO: TRDA (79.5M) vs MREO (500K).
MREOTRDAMREO / TRDA
Capitalization326M223M146%
EBITDA-47.49M-92.26M51%
Gain YTD-41.429-66.05063%
P/E RatioN/A10.26-
Revenue500K79.5M1%
Total Cash56.1M354M16%
Total Debt601K54.7M1%
FUNDAMENTALS RATINGS
MREO: Fundamental Ratings
MREO
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MREOTRDA
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
90%
Momentum
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
88%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 3 days ago
84%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
Bearish Trend 12 days ago
85%
Bearish Trend 6 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
MREO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AITUF11.94N/A
N/A
Anritsu Corp.
CPBLF10.95N/A
N/A
ALS Ltd.
SDIIF1.21N/A
N/A
Scientific Digital Imaging PLC
BMTLF0.06N/A
N/A
BeMetals Corp.
CHGCF48.59-0.46
-0.94%
Chugai Pharmaceutical Co., Ltd.

MREO and

Correlation & Price change

A.I.dvisor indicates that over the last year, MREO has been closely correlated with RARE. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if MREO jumps, then RARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MREO
1D Price
Change %
MREO100%
+2.50%
RARE - MREO
71%
Closely correlated
-3.93%
TRDA - MREO
44%
Loosely correlated
-5.02%
NRIX - MREO
40%
Loosely correlated
-1.89%
CRNX - MREO
39%
Loosely correlated
-1.75%
RGNX - MREO
36%
Loosely correlated
-4.94%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with XNCR. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-5.02%
XNCR - TRDA
51%
Loosely correlated
-1.20%
SYRE - TRDA
51%
Loosely correlated
+1.03%
CRNX - TRDA
51%
Loosely correlated
-1.75%
NRIX - TRDA
50%
Loosely correlated
-1.89%
IDYA - TRDA
50%
Loosely correlated
+5.67%
More